Nature Communications (Oct 2021)

CD177 modulates the function and homeostasis of tumor-infiltrating regulatory T cells

  • Myung-Chul Kim,
  • Nicholas Borcherding,
  • Kawther K. Ahmed,
  • Andrew P. Voigt,
  • Ajaykumar Vishwakarma,
  • Ryan Kolb,
  • Paige N. Kluz,
  • Gaurav Pandey,
  • Umasankar De,
  • Theodore Drashansky,
  • Eric Y. Helm,
  • Xin Zhang,
  • Katherine N. Gibson-Corley,
  • Julia Klesney-Tait,
  • Yuwen Zhu,
  • Jinglu Lu,
  • Jinsong Lu,
  • Xian Huang,
  • Hongrui Xiang,
  • Jinke Cheng,
  • Dongyang Wang,
  • Zheng Wang,
  • Jian Tang,
  • Jiajia Hu,
  • Zhengting Wang,
  • Hua Liu,
  • Mingjia Li,
  • Haoyang Zhuang,
  • Dorina Avram,
  • Daohong Zhou,
  • Rhonda Bacher,
  • Song Guo Zheng,
  • Xuefeng Wu,
  • Yousef Zakharia,
  • Weizhou Zhang

DOI
https://doi.org/10.1038/s41467-021-26091-4
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 13

Abstract

Read online

Regulatory T (Treg) cells are important modulators of the tumor microenvironment. Here the authors perform transcriptome profiling of immune cells from patients with renal clear cell carcinoma to find a Treg signature that correlates with poorer prognosis, with CD177 being implicated as the main mediator for related alterations in Treg activity and tumor outcome.